Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2019 Nov;12(11):e009723.
doi: 10.1161/CIRCIMAGING.119.009723. Epub 2019 Nov 11.

Long-Term Embolic Outcomes After Detection of Left Ventricular Thrombus by Late Gadolinium Enhancement Cardiovascular Magnetic Resonance Imaging: A Matched Cohort Study

Pratik S Velangi  1 , Christopher Choo  2 , Ko-Hsuan A Chen  1 , Felipe Kazmirczak  1 , Prabhjot S Nijjar  1 , Afshin Farzaneh-Far  3   4 , Osama Okasha  1 , Mehmet Akçakaya  5 , Jonathan W Weinsaft  6 , Chetan Shenoy  1
Affiliations
Observational Study

Long-Term Embolic Outcomes After Detection of Left Ventricular Thrombus by Late Gadolinium Enhancement Cardiovascular Magnetic Resonance Imaging: A Matched Cohort Study

Pratik S Velangi et al. Circ Cardiovasc Imaging. 2019 Nov.

Abstract

Background: Late gadolinium enhancement (LGE) cardiovascular magnetic resonance (CMR) imaging is more sensitive than echocardiography for the detection of intracardiac thrombus because of its unique ability to identify thrombus based on tissue characteristics related to avascularity. The long-term prognostic significance of left ventricular (LV) thrombus detected by LGE CMR is unknown.

Methods: We performed a matched cohort study of consecutive adult patients with LV thrombus detected by LGE CMR who were matched on the date of CMR, age, and LV ejection fraction to up to 3 patients without LV thrombus. We investigated the long-term incidence of a composite of embolic events: stroke, transient ischemic attack, or extracranial systemic arterial embolism. We also compared outcomes among patients with LV thrombus detected by LGE CMR stratified by whether the LV thrombus was also detected by echocardiography or not.

Results: Of 157 LV thrombus patients, 155 were matched to 400 non-LV thrombus patients. During a median follow-up of 3.3 years, the cumulative incidence of embolism was significantly higher in LV thrombus patients compared with the matched non-LV thrombus patients (P<0.001), with annualized rates of 3.7% and 0.8% for LV thrombus and matched non-LV thrombus patients, respectively. LV thrombus was the only independent predictor of the composite embolic end point (hazard ratio, 3.99 [95% CI, 1.54-10.35]; P=0.004). The cumulative incidence of embolism was not different in patients with LV thrombus that was also detected by echocardiography versus patients with LV thrombus not detected by echocardiography (P=0.25).

Conclusions: Despite contemporary antithrombotic treatment, LV thrombus detected by LGE CMR is associated with a 4-fold higher long-term incidence of embolism compared with matched non-LV thrombus patients. LV thrombus detected by LGE CMR but not by echocardiography is associated with a similar risk of embolism as that detected by both LGE CMR and echocardiography.

Keywords: adult; echocardiography; embolism; humans; magnetic resonance imaging; prognosis; thrombosis.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.. Examples of study patients.
Patient A had LV thrombus detected on LGE CMR and echocardiography and had an embolic outcome. Patient B had LV thrombus detected on LGE CMR but not echocardiography, and also had an embolic outcome. Patient C had no LV thrombus detected on LGE CMR and had no embolic outcome.
Figure 2.
Figure 2.. Incidence of embolism in LV thrombus patients compared with matched non-LV thrombus patients.
Kaplan-Meier curves demonstrate the cumulative incidence of the composite embolic endpoint in the LV thrombus (in red) and in the matched non-LV thrombus (in blue) groups. Note the significant difference in the cumulative incidence of embolic events between the 2 groups.
Figure 3.
Figure 3.. Incidence of embolism in patients with LV thrombus detected by echocardiography compared with patients with LV thrombus not detected by echocardiography.
Kaplan-Meier curves demonstrate the cumulative incidence of the composite embolic endpoint in patients with LV thrombus detected by echocardiography (in red) and in patients with LV thrombus not detected by echocardiography (in blue). Note the lack of a significant difference in the cumulative incidence of embolic events between the 2 groups.
See this image and copyright information in PMC

References

    1. Kamel H and Healey JS. Cardioembolic Stroke. Circ Res. 2017;120:514–526. - PMC - PubMed
    1. Lip GY, Ponikowski P, Andreotti F, Anker SD, Filippatos G, Homma S, Morais J, Pullicino P, Rasmussen LH, Marin F, et al. Thrombo-embolism and antithrombotic therapy for heart failure in sinus rhythm. A joint consensus document from the ESC Heart Failure Association and the ESC Working Group on Thrombosis. Eur J Heart Fail. 2012;14:681–95. - PubMed
    1. Loh E, Sutton MS, Wun CC, Rouleau JL, Flaker GC, Gottlieb SS, Lamas GA, Moye LA, Goldhaber SZ and Pfeffer MA. Ventricular dysfunction and the risk of stroke after myocardial infarction. N Engl J Med. 1997;336:251–7. - PubMed
    1. Bettari L, Fiuzat M, Becker R, Felker GM, Metra M and O’Connor CM. Thromboembolism and antithrombotic therapy in patients with heart failure in sinus rhythm: current status and future directions. Circ Heart Fail. 2011;4:361–8. - PubMed
    1. Weinsaft JW, Kim HW, Shah DJ, Klem I, Crowley AL, Brosnan R, James OG, Patel MR, Heitner J, Parker M, et al. Detection of left ventricular thrombus by delayed-enhancement cardiovascular magnetic resonance prevalence and markers in patients with systolic dysfunction. J Am Coll Cardiol. 2008;52:148–57. - PubMed

Publication types